Ad
related to: gilead sciences- Chipmaker Set to Soar Now
Best 2024 Semiconductor Stock?
One Chipmaker Worth Buying Now
- 3 Hottest Software Stocks
Top plays from a surging industry.
Free report names must-buy stocks.
- Top EV Stocks to Buy Now
5 EV Picks Better than Tesla
5 Stocks with Big Profit Potential
- Top Hydrogen Stock Plays
5 Hydrogen stocks to buy right now
New report names 5 wealth-builders
- Anti-Gold Investor Guide
Investments to buy instead of gold
Free guide to protect your wealth
- Free: Invest Like Buffett
5 "Buffett stocks" to buy right now
New report names 5 wealth-builders
- Chipmaker Set to Soar Now
Search results
ASCO: Cautious Big Pharmas double down on past wins—steering clear of radioligands and cell therapy
FierceBiotech· 1 hour agoThis year’s American Society of Clinical Oncology (ASCO) conference in Chicago marked a return to its pre-pandemic heyday. “I think that people finally are showing up like in the old days,” ...
KYTX Stock Sees Decline of Approximately
Knox Daily· 6 days agoInvestors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Kyverna Therapeutics Inc. shares valued at $20,020,000 were purchased by < ...
NJ Excels in Life Sciences & Med-Tech Industry Support
New Jersey Business Magazine· 11 hours agoWith the work of trade associations such as BioNJ and the HealthCare Institute of New Jersey, the...
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks via Yahoo Finance· 6 hours agoThis ETF has heaviest allocation in the Healthcare sector - about 99.90% of the portfolio. Taking...
Gilead’s Trodelvy misses goal in bladder cancer study
BioPharma Dive via Yahoo Finance· 5 days agoTreatment didn’t significantly improve overall survival in the trial, a finding that one analyst...
Buy Low, Hold Long: 2 Crushed Dividend Stocks To Buy For High Yields And Long-Term Gains
Benzinga via Yahoo Finance· 7 days agoSuccessful companies sometimes face events that could affect their stock performance. However,...
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WHTC 1450 Holland· 5 days agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than...
NIH launches 2 clinical trials testing HIV drug on women, other minority groups
United Press International via Yahoo News· 19 hours agoThe National Institute of Health says they are seeking to now include underrepresented population...
Gilead drug fails to confirm its FDA approval in bladder cancer - Silicon Valley Business Journal
The Business Journals· 5 days agoA drug at the center of a $21 billion acquisition by Gilead Sciences Inc. four years ago failed a...
Gilead Sciences Inc London Stock Price Today | NASDAQ 0QYQ Live Ticker - Investing.com
Investing.com· 6 days agoRisk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for ...